Search results for: tocilizumab

Biomarkers to Guide Diagnosis, Treatment of Rheumatic Diseases

Rick Brasington, MD | January 1, 2015

Examining the usefulness, drawbacks of current biomarkers in rheumatology and progress to develop better ones

Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss

Michele B. Kaufman, PharmD, BCGP | August 1, 2014

Plus, rheumatology drug news from EULAR 2014

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | July 1, 2014

An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid

What’s New in Inflammatory Arthritis?

Thomas R. Collins | June 1, 2014

Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair

Fellow’s Forum Case Report: Takayasu’s Arteritis

Ashwini Komarla, MD; Michael George, MD; Antoine Sreih, MD; & Chris Derk, MD, MS | May 1, 2014

How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease

Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

Atul Deodhar, MD | May 1, 2014

New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | January 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Fellow’s Forum Case Report: Arthritis, Fever, and Weight Loss In a Teenager Suggest A Rheumatic Condition

Jonathan S. Hausmann, MD | January 1, 2014

Joint pain and swelling flare up in a 14-year-old boy who tests positive for inflammation, thrombocytosis, and human leukocyte antigen B27

EULAR 2013: New RA Recommendations Address Combination Therapy Concerns

Thomas R. Collins | October 1, 2013

Guidelines give greater nod to use of combination conventional disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, leave monotherapy with methotrexate as acceptable first-line treatment

ACR Issues sJIA Recommendations, SSc Classification Criteria

Kathy Holliman | October 1, 2013

Guidelines address advances in pathophysiology and treatment of systemic juvenile idiopathic arthritis; criteria classify broader spectrum of systemic sclerosis